Skip to main content
Clinical Trials/ACTRN12611000601932
ACTRN12611000601932
Terminated
未知

A prospective comparison of corneal cross linking treatment parameters and outcomes for juvenile onset early keratoconus

Dr James MC Alister0 sites102 target enrollmentJune 10, 2011

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr James MC Alister
Enrollment
102
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 10, 2011
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr James MC Alister

Eligibility Criteria

Inclusion Criteria

  • Early Keratoconus must be evidenced by one or more of the following Pentacam derived topographic abnormalities in the study eye
  • 1\. Corneal shape factor indicative of keratoconus on Pentacam assessment
  • Abnormal Enhanced Ectasia Display flags abnormalities based on regression analysis of findings compared to normality indices for
  • (A) Corneal thickness spatial profile (CTSP)
  • (B) Percentage thickness increase (PTI)
  • (C) Deviation parameters (D)
  • 2\. Thinnest pachymetry of less than 480microm
  • 3\. Kmax of greater than 48 D
  • 4\. Posterior corneal elevation of greater than 25 microm on Pentacam analysis
  • and be associated with patient reported history, topographic or refraction data which indicates one of the following changes notes in less than a 12 month period of follow up.

Exclusion Criteria

  • Exclusion criteria
  • Eyes will not be eligible to be recruited into the trial if anyone or more of the following apply:
  • 1\. Patient age is 18 years or older
  • 2\. There is a history of previous corneal surgery.
  • 3\. Corneal pachymetry of less than 340microm (thinnest point measured by Pentacam topographer.
  • 4\. Insufficient ability to comply with full testing involved in the study
  • 5\.The presence of visually significant corneal stromal scarring.
  • 6\. The existence of other corneal pathology.
  • 7\. A history of herpetic keratitis, chemical injury, or delayed epithelial healing.
  • 8\. Recurrent corneal erosion syndrome.

Outcomes

Primary Outcomes

Not specified

Similar Trials